GM3 and insulin sensitivity.
- Conditions
- Diabetes, obesity, insulin resistance,
- Registration Number
- NL-OMON21599
- Lead Sponsor
- Academic Medical Center (AMC), Department of Endocrinology and Metabolism
- Brief Summary
/A
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- Not specified
- Target Recruitment
- 20
Inclusion Criteria
Inclusion criteria for all participants
1. Written informed consent
Exclusion Criteria
Exclusion criteria for all participants:
1. Participation in an investigational drug trial within 90 days prior to our study
Study & Design
- Study Type
- Observational non invasive
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method - Peripheral glucose uptake (Rd)<br /><br>- Ganglisosides concentration in muscle and adipose tissue<br>
- Secondary Outcome Measures
Name Time Method - Plasma concentration of glucoregulatory hormones<br /><br>- Energy expenditure<br /><br>- Carbohydrate oxidation and fat oxidation<br /><br>- VO2 max<br /><br>- Muscle fiber type<br /><br>